🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Aflibercept - Medicines in Ireland

17 authorised products containing Aflibercept, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 17 authorised medicines
MedicineActive substanceLicence holderStatus
Afqlir
EU/1/24/1867/001
Aflibercept Sandoz GmbH
Afqlir
EU/1/24/1867/002
Aflibercept Sandoz GmbH
Ahzantive 40 mg/ml Solution for injection
EU/1/24/1888/001
Aflibercept Formycon AG
Baiama 40 mg/mL solution for injection in a vial
EU/1/24/1887/001
Aflibercept Formycon AG
Eylea 114.3 mg/ml solution for injection
EU/1/12/797/003
Aflibercept Bayer AG
Eylea 114.3 mg/ml solution for injection in pre-filled syringe
EU/1/12/797/004
Aflibercept Bayer AG
Eylea 40 mg/mL solution for injection
EU/1/12/797/001-002
Aflibercept Bayer AG
Eyluxvi 40mg/ml Solution for injection in vial
EU/1/25/1972/001
Aflibercept Biolitec Pharma Limited
MYNZEPLI 40 mg/mL solution for injection in a vial
EU/1/25/1964/001
Aflibercept Advanz Pharma Limited
MYNZEPLI 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1964/002
Aflibercept Advanz Pharma Limited
Opuviz 40 mg/mL solution for injection in a vial
EU/1/24/1865/001-002
Aflibercept Samsung Bioepis NL B.V.
PAVBLU 40 mg/mL solution for injection in a vial
EU/1/25/1909/002
Aflibercept Amgen Technology (Ireland) Unlimited Company
PAVBLU 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1909/001
Aflibercept Amgen Technology (Ireland) Unlimited Company
Vgenfli 40 mg/mL solution for injection in a vial
EU/1/25/1961/002
Aflibercept Zaklady Farmaceutyczne Polpharma S.A.
Vgenfli 40 mg/mL solution for injection in pre-filled syringe
EU/1/25/1961/001
Aflibercept Zaklady Farmaceutyczne Polpharma S.A.
Yesafili 40 mg/mL solution for injection in pre-filled syringe.
EU/1/23/1751/001-002
Aflibercept Biosimilar Collaborations Ireland Limited
ZALTRAP 25 mg/ml concentrate for solution for infusion
EU/1/12/814/001-003
Aflibercept Sanofi Winthrop Industrie
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.